National HealthCare Corporation
NHC Healthcare Medical Care Facilities
National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024.
- Revenue
- +6.61%
- EPS
- −65.6%
- Free cash flow
- +75.5%
- Total debt
- +216.7%
Quarter to September 2026, against a year earlier
Follow NHC
Alert me
National HealthCare Corporation (NHC) EV/EBITDA
As of 5 November 2026, National HealthCare Corporation (NHC) trades at a EV/EBITDA of 16.1×. Over the past ten years it has ranged from 6.0× (August 2015) to 19.4× (October 2026); the current reading is higher than 97% of that period. That is above the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 10.9× | (5.75%) |
| FY2024 | 11.5× | (7.86%) |
| FY2023 | 12.5× | 37.73% |
| FY2022 | 9.1× | 9.71% |
| FY2021 | 8.3× | 8.05% |
| FY2020 | 7.7× | (34.76%) |
| FY2019 | 11.8× | 20.15% |
| FY2018 | 9.8× | 34.13% |
| FY2017 | 7.3× | (23.03%) |
| FY2016 | 9.5× | 42.95% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 17.1× | 4.77% |
| Jun 2026 | 16.3× | 27.62% |
| Mar 2026 | 12.8× | 17.58% |
| Dec 2025 | 10.9× | 14.21% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| ACHC Acadia Healthcare Company, Inc. compare | 9.9× |
| MD Pediatrix Medical Group, Inc. compare | 11.0× |
| SGRY Surgery Partners, Inc. compare | 11.2× |
| ADUS Addus HomeCare Corporation compare | 13.0× |
| OPCH Option Care Health, Inc. compare | 13.7× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 14.1× |
| BKD Brookdale Senior Living Inc. compare | 14.9× |
| NHC National HealthCare Corporation | 16.1× |
| GRDN Guardian Pharmacy Services, Inc. compare | 20.7× |
| Medical Care Facilities industry median | 11.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on NHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement